Lower levels of circulating TNF-α+ expressing B cells in patients compared to HV, and TNF-α+ expressing B cells proportionally less highly represented in the B cell TME compartment compared to patient blood may denote a degree of regulation of the pro-inflammatory humoral immune compartment in melanoma. This evidence concerns the gene TNF and melanoma.